adenosine diphosphate has been researched along with Carotid Artery Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jin, R; Li, G; Nanda, A; Wang, C; Yan, J | 1 |
Goodall, AH; Hayes, PD; Jones, CI; McMahon, GS; Naylor, AR; Webster, SE | 1 |
Böhm, A; Driessen, J; Ermler, S; Fischer, JW; Jakubowski, JA; Rauch, BH; Rosenkranz, AC; Schrör, K; Sugidachi, A | 1 |
1 trial(s) available for adenosine diphosphate and Carotid Artery Diseases
Article | Year |
---|---|
Low molecular weight heparin significantly reduces embolisation after carotid endarterectomy--a randomised controlled trial.
Topics: Adenosine Diphosphate; Aged; Anticoagulants; Arachidonic Acid; Aspirin; Carotid Artery Diseases; Dalteparin; Double-Blind Method; Drug Therapy, Combination; Endarterectomy, Carotid; Female; Hemorrhage; Heparin; Humans; Infusions, Intravenous; Intracranial Embolism; Male; Middle Aged; Odds Ratio; Platelet Aggregation; Platelet Aggregation Inhibitors; Risk Assessment; Stroke; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Transcranial | 2009 |
2 other study(ies) available for adenosine diphosphate and Carotid Artery Diseases
Article | Year |
---|---|
Platelet PI3Kγ Contributes to Carotid Intima-Media Thickening under Severely Reduced Flow Conditions.
Topics: Adenosine Diphosphate; Animals; Blood Platelets; Carotid Artery Diseases; Cell Adhesion; Cell Communication; Chemotaxis, Leukocyte; Class Ib Phosphatidylinositol 3-Kinase; Cytokines; Disease Models, Animal; Endothelial Cells; Gene Expression; Hemodynamics; Inflammation Mediators; Leukocytes; Male; Mice; p38 Mitogen-Activated Protein Kinases; Platelet Activation; Proto-Oncogene Proteins c-akt; Tunica Intima | 2015 |
Regulation of functionally active P2Y12 ADP receptors by thrombin in human smooth muscle cells and the presence of P2Y12 in carotid artery lesions.
Topics: Adenosine Diphosphate; Carotid Artery Diseases; Cell Proliferation; Cells, Cultured; Cyclic AMP; Humans; Interleukin-6; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B; Piperazines; Purinergic P2Y Receptor Agonists; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; RNA Interference; RNA, Messenger; Thionucleotides; Thrombin; Time Factors; Transcriptional Activation; Up-Regulation | 2010 |